Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
lunes, octubre 19
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Bluejay Diagnostics Inc
BJDX
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$0.7151
-0.0294
-3.95%
Últ. Act.: Oct 19, 11:57 AM
$0.7426
-0.0019
-0.26%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Privacy Manager
Bluejay Diagnostics Financials
Bluejay Diagnostics (BJDX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Bluejay Diagnostics Q2 EPS $(1.12) Up From $(5.64) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.12) per share. This is a 80.14 percent increase over losses of $(5.64) per share from the same period last year.
Benzinga Newsdesk
PRO
Bluejay Diagnostics Q1 EPS $(1.95) Up From $(13.48) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.95) per share. This is a 85.53 percent increase over losses of $(13.48) per share from the same period last year.
Benzinga Newsdesk
PRO
Bluejay Diagnostics Q2 EPS $(1.41) Up From $(256.16) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.41) per share. This is a 99.45 percent increase over losses of $(256.16) per share from the same period last year.
Benzinga Newsdesk
PRO
Bluejay Diagnostics Q1 EPS $(3.37) Up From $(394.76) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(3.37) per share. This is a 99.15 percent increase over losses of $(394.76) per share from the same period last year.
Benzinga Newsdesk
Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings
Avi Kapoor
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March
Avi Kapoor
